[16] reported mostly mild side effects across agents, with more diarrhea in liraglutide users than exenatide
Pregnancy and breastfeeding : GLP-1 receptor agonists are not recommended during pregnancy
Decades of subsequent preclinical research documented BPC-157 activity across gastrointestinal tissue, tendons, ligaments, bone, and the nervous system
Alva ML, Gray A, Mihaylova B, Leal J, Holman RR
Baseline WOMAC pain score: approximately 6 out of 20 Reduction in active treatment arms: approximately 4.5 points , representing a ~76% decrease from baseline Complete freedom from knee pain at week 68: reported by roughly 1 in 8 patients (12.5%) receiving retatrutide, compared to just 4.2% in the placebo group A 76% reduction in pain scores is extraordinary approaching the range typically seen after total knee replacement surgery
United States code: social security act, U.S.C